Carisma Therapeutics Inc. Deferred Revenue
Carisma Therapeutics Inc. had Deferred Revenue of $0 as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2025-11-12
- 2025-09-30: Deferred Revenue, Current $0.00.
- 2025-06-30: Deferred Revenue, Current $0.00.
- 2025-03-31: Deferred Revenue, Current $0.00.
- 2024-12-31: Deferred Revenue, Current $3.73M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.73M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $682.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $659.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.19M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.41M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.19M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.42M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.14M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.46M 10-K · filed 2024-04-01 |
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-17 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 |
| 2016-12-31 | $425.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | $1.25M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 |
| 2016-03-31 | $203.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $406.00K 10-K · filed 2017-03-24 |
| 2015-09-30 | $471.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $451.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $262.00K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $506.00K 10-K · filed 2016-03-25 |
| 2014-09-30 | $621.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $643.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.13M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.11M 10-K · filed 2015-03-06 |